Literature DB >> 20722710

Natalizumab treatment in paediatric multiple sclerosis: a case of induction, de-escalation and escalation.

Norman Putzki, Oliver Stich, Kristina Gartzen, Oliver Kastrup, Barbara Tettenborn, Sebastian Rauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20722710     DOI： 10.1111/j.1468-1331.2010.03178.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  2 in total

1.  Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS.

Authors:  Angelo Ghezzi; Giancarlo Comi; Luigi Maria Grimaldi; Lucia Moiola; Carlo Pozzilli; Simone Fantaccini; Paolo Gallo
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-07-01

Review 2.  Use of Disease-Modifying Therapies in Pediatric MS.

Authors:  Marta Simone; Tanuja Chitnis
Journal:  Curr Treat Options Neurol       Date:  2016-08       Impact factor: 3.972
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.